The Efficacy of Distortion Banding on Outcome Measures in Children With Cerebral Palsy

Overview

The aim of the study is to compare the conventional rehabilitation program and the distortion taping applied with Kinesio Tex tape in addition to conventional rehabilitation in children with hemiplegic or monoplegic cerebral palsy with ankle varus deformity.

Full Title of Study: “The Efficacy of Distortion Taping on Balance, Performance, Gait, Spasticity and Quality of Life in Ankle Varus Deformity in Children With Cerebral Palsy”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Treatment
    • Masking: None (Open Label)
  • Study Primary Completion Date: August 15, 2022

Detailed Description

Conventional rehabilitation practices will be applied to the control group. In addition to Kinesio Tex tape distortion taping, conventional rehabilitation will be applied to the intervention group. It is aimed to evaluate the patients' balance, quality of life, performance test, spasticity level and gait quality.

Interventions

  • Other: Kinesio Taping
    • In addition to Kinesio Tex tape distortion taping, conventional rehabilitation is applied.
  • Other: Conventional Rehabilitation
    • Conventional rehabilitation practices are carried out

Arms, Groups and Cohorts

  • Experimental: Kinesio Taping Group (KTG)
    • Distortion taping with Kinesio Tex will be applied to the patients in addition to conventional rehabilitation through a pediatric physiotherapist.
  • Active Comparator: Conventional Rehabilitation Group (CRG)
    • Conventional rehabilitation program will be applied to the patients through a pediatric physiotherapist.

Clinical Trial Outcome Measures

Primary Measures

  • TUG
    • Time Frame: Change from Baseline TUG at 3 days
    • Patients are asked to get up from a standard chair, walk 3 meters at a safe and comfortable pace, and return without stopping to sit back in the chair safely. The elapsed time is calculated. There is no score range in TUG.
  • SLS
    • Time Frame: Change from Baseline SLS at 3 days
    • The one-leg standing test measures the time one is able to stand on one lower limb without support. There is no score range in SLS.
  • Modified Ashworth Scale (MAS)
    • Time Frame: Change from Baseline MAS at 3 days
    • The Modified Ashworth Scale is a 6-point rating scale for gauging muscle resistance to passive movement. MAS is scored from 0 to 4, where lower scores represent normal muscle tone and higher scores represent spasticity.
  • WGS
    • Time Frame: Change from Baseline WGS at 3 days
    • The scale allows for a multifactorial gait analysis, takes in to account 14 observable gait parameters divided into four sub-scales referring to particular phases of gait, i.e. stance phase, toe off, swing phase, andheel strike. WGS is scored from 13.35 to 42.0. Higher scores indicate higher impairment.
  • CHQ
    • Time Frame: Change from Baseline CHQ at 3 days
    • The CHQ is a validated multidimensional instrument that measures the functional health and well-being of children and young people. CHQ is scored from 0 to 100. Higher scores indicate better health status.

Participating in This Clinical Trial

Inclusion Criteria

  • Children with cerebral palsy aged 4-12 years with unilateral involvement who are hemiplegic or monoplegic – Cases with Gross Motor Function Classification (GMFCS) level 1 or 2 – Understanding simple commands and signing the consent form Exclusion Criteria:

  • Presence of equinus deformity – Situations that may prevent assessments or communication – Lack of cooperation during work – Presence of surgery that may affect assessments, such as joint freezing – Presence of botulinum toxin administration in the last 6 months – Development of an allergic reaction on the skin to the tape

Gender Eligibility: All

Minimum Age: 4 Years

Maximum Age: 12 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Muğla Sıtkı Koçman University
  • Provider of Information About this Clinical Study
    • Principal Investigator: Fatih Ozden, Principal Investigator – Muğla Sıtkı Koçman University
  • Overall Official(s)
    • Ahmet İmerci, PhD, Principal Investigator, Muğla Sıtkı Koçman University
    • İsmet Tümtürk, BSc, Principal Investigator, Ege University

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.